PLoS Computational BiologyBioinformaticsPeer-reviewed journal article
LOTUS: a Single- and Multitask Machine Learning Algorithm for the Prediction of Cancer Driver Genes
Abstract
Cancer driver genes, i.e., oncogenes and tumor suppressor genes, are involved in the acquisition of important functions in tumors, providing a selective growth advantage, allowing uncontrolled proliferation and avoiding apoptosis. It is therefore important to identify these driver genes, both for the fundamental understanding of cancer and to help finding new therapeutic targets. Although the most frequently mutated driver genes have been identified, it is believed that many more remain to be discovered, particularly for driver genes specific to some cancer types.\n\nIn this paper we propose a new computational method called LOTUS to predict new driver genes. LOTUS is a machine-learning based approach which allows to integrate various types of data in a versatile manner, including informations about gene mutations and protein-protein interactions. In addition, LOTUS can predict cancer driver genes in a pan-cancer setting as well as for specific cancer types, using a multitask learning strategy to share information across cancer types.\n\nWe empirically show that LOTUS outperforms three other state-of-the-art driver gene prediction methods, both in terms of intrinsic consistency and prediction accuracy, and provide predictions of new cancer genes across many cancer types.\n\nAuthor summaryCancer development is driven by mutations and dysfunction of important, so-called cancer driver genes, that could be targeted by targeted therapies. While a number of such cancer genes have already been identified, it is believed that many more remain to be discovered. To help prioritize experimental investigations of candidate genes, several computational methods have been proposed to rank promising candidates based on their mutations in large cohorts of cancer cases, or on their interactions with known driver genes in biological networks. We propose LOTUS, a new computational approach to identify genes with high oncogenic potential. LOTUS implements a machine learning approach to learn an oncogenic potential score from known driver genes, and brings two novelties compared to existing methods. First, it allows to easily combine heterogeneous informations into the scoring function, which we illustrate by learning a scoring function from both known mutations in large cancer cohorts and interactions in biological networks. Second, using a multitask learning strategy, it can predict different driver genes for different cancer types, while sharing information between them to improve the prediction for every type. We provide experimental results showing that LOTUS significantly outperforms several state-of-the-art cancer gene prediction softwares.
- research focus: variant effect prediction
- research focus: gene regulatory network inference
- research focus: benchmarking
- approach: machine learning (classical)
- approach: statistical model
- Citations
- 57
- FWCI
- 1.74
- Field percentile
- top 17%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Ontology-based prediction of cancer driver genes
Sara Althubaiti, Andreas Karwath, … Robert Hoehndorf·Scientific ReportsPeer-reviewed·Nov 22, 2019
- Evaluating the Evaluation of Cancer Driver Genes
Collin Tokheim, Nickolas Papadopoulis, … Rachel Karchin·bioRxiv·Jun 23, 2016
- ConsensusDriver Improves Upon Individual Algorithms For Predicting Driver Alterations In Different Cancer Types And Individual Patients -- A Toolbox For Precision Oncology
Denis Bertrand, Sibyl Drissler, … Niranjan Nagarajan·Cancer ResearchPeer-reviewed·Dec 19, 2017
- Machine learning predictions improve identification of real-world cancer driver mutations
Thinh Ngoc Tran, Chris Fong, … Justin Jee·bioRxiv·Mar 31, 2024
- Novel ratio-metric features enable the identification of new driver genes across cancer types
M. Sudhakar, R. Rengaswamy, K. Raman·bioRxiv·Jan 17, 2020
- Multi-omic data helps improve prediction of personalised tumor suppressors and oncogenes
Malvika Sudhakar, Raghunathan Rengaswamy, Karthik Raman·Frontiers in GeneticsPeer-reviewed·May 10, 2022